產品

A novel autologous adipose-derived stem cell therapy for treating liver cirrhosis, focusing on reducing hepatic inflammation and reversing liver fibrosis.

A novel autologous adipose-derived stem cell therapy for treating chronic stroke, focusing on angiogenesis, neural differentiation, and motor function improvement.

An allogeneic adipose-derived stem cell therapy for treating osteoarthritis, focusing on pain relief, cartilage regeneration, and knee function improvement.

An allogeneic adipose-derived stem cell therapy for type 1 diabetes, focusing on regulating blood sugar, protecting islets, and reduction of insulin dependence.